NewsBenzingaBereits gemeldet: Vivos Therapeutics Q3 EPS von $(0,07) übertrifft die Schätzung von $(0,42), Umsatz von 6,414 Mio. $ übertrifft die Schätzung von 5,937 Mio. $ Bereits gemeldet: Vivos Therapeutics Q3 EPS von $(0,07) übertrifft die Schätzung von $(0,42), Umsatz von 6,414 Mio. $ übertrifft die Schätzung von 5,937 Mio. $ Benzinga 2026.11.17 06:16 (GMT+0) Open on Benzinga Other news CalPERS Discloses $37.1 Million Stake in Strategy Scammers Used Musk Deepfake Video to Defraud; Coinbase AI System Blocked $4.7 Million JPMorgan Is Developing AI Agent Trading Without Human Involvement Coinbase CEO: AI Agents to Account for Well Over 99.9% of Trading Volume Within a Decade; Bitcoin May Have Bottomed This Cycle Jito CEO: Crypto Developers Should Slow Down in the Next Two Years and Focus on Fixing Security Flaws Glassnode: Bitcoin Sell-Off Nears Historical Local Bottom Levels, $62,000 Becomes Key Line of Defense
Coinbase CEO: AI Agents to Account for Well Over 99.9% of Trading Volume Within a Decade; Bitcoin May Have Bottomed This Cycle
Jito CEO: Crypto Developers Should Slow Down in the Next Two Years and Focus on Fixing Security Flaws
Glassnode: Bitcoin Sell-Off Nears Historical Local Bottom Levels, $62,000 Becomes Key Line of Defense